|
(P1356)
|
Perioperatives Management mit kurzwirksamem GPIIb/IIIa-Hemmer bei Patienten mit Koronarstents und nicht-kardialer OP
|
|
A. May, B. Bigalke, P. Seizer, C. S. Zürn, M. Gawaz (Tübingen)
|
|
(P1357)
|
Assessment of antiplatelet effect of clopidogrel after selective dose-adjustment in a large cohort of patients following percutaneous coronary intervention with stent implantation
|
|
D. Trenk, K. Allgaier, W. Hochholzer, S. Leggewie, M. Cap, C. M. Valina, C. Stratz, H.-P. Bestehorn, H. J. Büttner, F.-J. Neumann (Bad Krozingen)
|
|
(P1358)
|
Rebound der Plättchenaggregabilität nach Absetzen von Clopidogrel
|
|
P. Diehl, C. Halscheid, C. Olivier, C. Bode, M. Moser (Freiburg im Breisgau)
|
|
(P1359)
|
Reduction of platelet reactivity by bivalirudin post coronary intervention.
|
|
U. Rauch-Kröhnert, W. Pepke, C. Stellbaum, Y. Ayral, W. Knie, M. Jaster, A. J. Morguet, B. Witzenbichler, H.-P. Schultheiss (Berlin)
|
|
(P1360)
|
Prehospital Administration of Clopidogrel in Patients with ST Elevation Myocardial Infarction is Associated with Impaired P2Y12 Inhibition and Increased Cardiovascular Events
|
|
A. Schäfer, U. Flierl, N. Seydelmann, J. Kössler, A. Kobsar, S. Störk, U. Walter, J. Bauersachs (Würzburg)
|
|
(P1361)
|
One Year Outcomes of High Loading Dose Clopidogrel with or without Abciximab in Patients with Acute Myocardial Infarction undergoing Primary Percutaneous Coronary Intervention.
|
|
S. Massberg, J. Mehilli, S. Schulz, K. A. Birkmeier, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, A. Kastrati, A. Schömig (München, Traunstein, Garmisch-Partenkirchen; Wien, AT)
|
|
(P1362)
|
Cofactors of Paradox Reaction to Acetylsalicylic Acid in Patients with Coronary Artery Disease
|
|
Z. Wang, J. Hutschenreuther, G. Nowak, T. Kaden, J. Hentrich, H.-R. Figulla, M. Ferrari (Jena)
|
|
(P1363)
|
Impact of cytochrome 2C19*17 allelic variant on platelet aggregation and bleeding events in clopidogrel treated patients with coronary stent placement
|
|
D. Sibbing, W. Koch, D. Gebhard, T. Schuster, S.-L. Braun, J. Stegherr, T. Morath, A. Schömig, N. von Beckerath, A. Kastrati (München)
|
|
(P1364)
|
Impact of systemic inflammation on platelet aggregation in patients under chronic clopidogrel treatment
|
|
I. Bernlochner, S. Steinhubl, S.-L. Braun, T. Morath, J. Mehilli, J. Stegherr, A. Schömig, N. von Beckerath, A. Kastrati, D. Sibbing (München; Zürich, CH)
|
|
(P1365)
|
Baseline inflammatory markers are associated with platelet responses to dual antiplatelet therapy in patients undergoing coronary intervention.
|
|
K. A. L. Müller, S. Aichele, P. Caponetto, M. Gosheva, C. S. Zürn, E. Ninci, M. Herkommer, P. Htun, R. Jorbenadze, S. Fateh-Moghadam, M. Gawaz, T. Geisler (Tübingen)
|